AAAAAA

   
Results: 1-9 |
Results: 9
Rb, mcl-1 and p53 expression correlate with clinical outcome in patients with liver metastases from colorectal cancer
Authors: Backus, HHJ van Riel, JMGH van Groeningen, CJ Vos, W Dukers, DF Bloemena, E Wouters, D Pinedo, HM Peters, GJ
Citation: Hhj. Backus et al., Rb, mcl-1 and p53 expression correlate with clinical outcome in patients with liver metastases from colorectal cancer, ANN ONCOL, 12(6), 2001, pp. 779-785
5-Fluorouracil induced Fas upregulation associated with apoptosis in livermetastases of colorectal cancer patients
Authors: Backus, HHJ Dukers, DF van Groeningen, CJ Vos, W Bloemena, E Wouters, D van Riel, JMGH Smid, K Giaccone, G Pinedo, HM Peters, GJ
Citation: Hhj. Backus et al., 5-Fluorouracil induced Fas upregulation associated with apoptosis in livermetastases of colorectal cancer patients, ANN ONCOL, 12(2), 2001, pp. 209-216
Modulation of both endogenous folates and thymidine enhance the therapeutic efficacy of thymidylate synthase inhibitors
Authors: van der Wilt, CL Backus, HHJ Smid, K Comijn, L Veerman, G Wouters, D Voorn, DA Priest, DG Bunni, MA Mitchell, F Jackman, AL Jansen, G Peters, GJ
Citation: Cl. Van Der Wilt et al., Modulation of both endogenous folates and thymidine enhance the therapeutic efficacy of thymidylate synthase inhibitors, CANCER RES, 61(9), 2001, pp. 3675-3681
The multilayered postconfluent cell culture as a model for drug screening
Authors: Padron, JM van der Wilt, CL Smid, K Smitskamp-Wilms, E Backus, HHJ Pizao, PE Giaccone, G Peters, GJ
Citation: Jm. Padron et al., The multilayered postconfluent cell culture as a model for drug screening, CR R ONC H, 36(2-3), 2000, pp. 141-157
Differences in the induction of DNA damage, cell cycle arrest, and cell death by 5-fluorouracil and antifolates
Authors: Backus, HHJ Pinedo, HM Wouters, D Kuiper, CM Jansen, G van Groeningen, CJ Peters, GJ
Citation: Hhj. Backus et al., Differences in the induction of DNA damage, cell cycle arrest, and cell death by 5-fluorouracil and antifolates, ONCOL RES, 12(5), 2000, pp. 231-239
Molecular downstream events and induction of thymidylate synthase in mutant and wild-type p53 colon cancer cell lines after treatment with 5-fluorouracil and the thymidylate synthase inhibitor raltitrexed
Authors: Peters, GJ van Triest, B Backus, HHJ Kuiper, CM van der Wilt, CL Pinedo, HM
Citation: Gj. Peters et al., Molecular downstream events and induction of thymidylate synthase in mutant and wild-type p53 colon cancer cell lines after treatment with 5-fluorouracil and the thymidylate synthase inhibitor raltitrexed, EUR J CANC, 36(7), 2000, pp. 916-924
Thymidylate synthase expression in patients with colorectal carcinoma using a polyclonal thymidylate synthase antibody in comparison to the TS 106 monoclonal antibody
Authors: Van Triest, B Loftus, BM Pinedo, HM Backus, HHJ Schoenmakers, P Telleman, F Tadema, T Aherne, GW Van Groeningen, CJ Zoetmulder, FAN Taal, BG Johnston, PG Peters, GJ
Citation: B. Van Triest et al., Thymidylate synthase expression in patients with colorectal carcinoma using a polyclonal thymidylate synthase antibody in comparison to the TS 106 monoclonal antibody, J HIST CYTO, 48(6), 2000, pp. 755-760
Folate depletion increases sensitivity of solid tumor cell lines to 5-fluorouracil and antifolates
Authors: Backus, HHJ Pinedo, HM Wouters, D Padron, JM Molders, N van der Wilt, CL van Groeningen, CJ Jansen, G Peters, GJ
Citation: Hhj. Backus et al., Folate depletion increases sensitivity of solid tumor cell lines to 5-fluorouracil and antifolates, INT J CANC, 87(6), 2000, pp. 771-778
Influence of cytotoxicity enhancers in combination with human serum on theactivity of CD22-recombinant ricin A against B cell lines, chronic and acute lymphocytic leukemia cells
Authors: van Horssen, PJ van Oosterhout, YVJM Evers, S Backus, HHJ van Oijen, MGCT Bongaerts, R de Witte, T Preijers, FWMB
Citation: Pj. Van Horssen et al., Influence of cytotoxicity enhancers in combination with human serum on theactivity of CD22-recombinant ricin A against B cell lines, chronic and acute lymphocytic leukemia cells, LEUKEMIA, 13(2), 1999, pp. 241-249
Risultati: 1-9 |